Press Releases

JERSEY CITY, N.J., Oct. 24, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced an amendment to the protocol for the ongoing FURI study investigating the safety and efficacy of oral ibrexafungerp (formerly SCY-078) as a salvage treatme

RANCHO CORDOVA, Calif., Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu, Ph.D., Chairman and Chief Executive Officer, will present a company overview at the Dawson James Securities 5t

SAN DIEGO, Oct. 24, 2019 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developmen

NORTH CHICAGO, Ill., Oct. 24, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Wolfe Research Inaugural Healthcare Conference on Wednesday, November 6.  Richard A. Gonzalez, chairman and chief executive officer, will present at 8:30 a.m. Central

SEATTLE, Oct. 24, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected as winner of the "Remote Monitoring in Arrhythmias" Technology and Innovation Pitch Session held as part of the

PALO ALTO, Calif., Oct. 24, 2019 /PRNewswire/ -- SightGlass Vision, Inc., a medical device company developing spectacle lenses to slow the progression of nearsightedness or myopia in children, today announced that data from three clinical trials overviewing discovery to clinical development of its novel spectacle lenses will be presented for the first time in a scie

PALO ALTO, Calif., Oct. 24, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it was selected by The Ohio State University to equip a new multi-room proton therapy center in central Ohio with the ProBeam 360° system. This new proton facility is a collaboration between The Ohio Sta

ZUG, Switzerland, Oct. 24, 2019 /PRNewswire/ -- Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Mr. Dan Spacie, as Global Commercial Head to the Executive Management Team led by CEO Alan Knox.Dan Spacie has joined Primex Pharmaceu

TORONTO, Oct. 24, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

FORT WORTH, Texas, Oct. 24, 2019 /PRNewswire/ -- Galderma, a global leader in skin health focused on developing innovative aesthetic solutions, continues its strong investment in products and research that advance the aesthetics industry with seven new clinical studies recently initiated.